Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells

Peritoneal Dialysis International

Volumn 22, Issue 2, 2002, Pages 171-177

  Ha, Hunjoo ^a   Cha, Mi Kyung ^a   Choi, Hoo Nam ^a   Lee, Hi Bahl ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Fibronectin; Glucose degradation products; High glucose; Human peritoneal mesothelial cells; Peritoneal dialysis solutions; Procollagens; Transforming growth factor; Vascular endothelial growth factor

Indexed keywords

BICARBONATE; DIANEAL; EXTRANEAL; FIBRONECTIN; GLUCOSE; GLUCOSE DEGRADATION PRODUCT; GROWTH FACTOR; ICODEXTRIN; LACTIC ACID; PERITONEAL DIALYSIS FLUID; PHYSIONEAL; PROCOLLAGEN C PROTEINASE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL SYNCHRONIZATION; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; KIDNEY FIBROSIS; MEMBRANE PERMEABILITY; MESOTHELIUM CELL; PERITONEUM; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOIMMUNOASSAY;

EID: 0036099846     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080202200202     Document Type: Article

References (33)

1. Increased peritoneal membrane transport is associated with decreased patient and technical survival for continuous peritoneal dialysis patients
2. Peritoneal transport characteristics, comorbid disease and survival in CAPD patients
3. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity
4. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis
5. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal properties
6. Growth factors VEGF and TGF-β1 in peritoneal dialysis
7. Vascular endothelial growth factor in peritoneal dialysis: A longitudinal follow-up
8. The role of TGF-β in growth inhibition of peritoneal mesothelial cells in high-glucose dialysate
9. High glucose-induced PKC activation mediates TGF-β and fibronectin synthesis by human peritoneal mesothelial cells
10. Neoangiogenesis in the peritoneal membrane
11. Molecular and biological properties of the vascular endothelial growth factor family of proteins
12. Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis
13. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: Role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis
14. Role of vascular endothelial growth factor in diabetic vascular complications
15. Role of vascular endothelial growth factor in diabetic nephropathy
16. Involvement of transforming growth factor-β and its receptors in the pathogenesis of diabetic nephropathy
17. Effect of high glucose on peritoneal mesothelial cell biology
18. Type I and III procollagen in CAPD: Markers of peritoneal fibrosis
19. Procollagen type I (PICP) in CAPD patients
20. Type III and type I procollagen markers in fibrosing alveolitis
21. Modulation of skin collagen metabolism by irradiation: Collagen synthesis is increased in irradiated human skin
22. Effects of conventional and new peritoneal dialysis solutions on human peritoneal mesothelial cell viability and proliferation
23. Reduced glucose degradation products in bicarbonate/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags
24. Glucose degradation products and the peritoneal mesothelium
25. Reduced 1,2-dicarbonyl compounds in bicarbonate/lactate-buffered peritoneal dialysis (PD) fluids and PD fluid based on glucose polymers or amino acids
26. Isolation, culture, and characterization of human peritoneal mesothelial cells
27. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
28. Effect of glucose on TGF-β1 expression in peritoneal mesothelial cells
29. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-β1 of human peritoneal mesothelial cells: Effect of cytokine costimulation
30. Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels
31. Increase in wound breaking strength in rats in the presence of positively charged dextran beads correlates with an increase in endogenous transforming growth factor-β1 and its receptor TGF-βRI in close proximity to the wound
32. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products
33. Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: Effects on TGF-β